ANNX

Annexon, Inc.

• Dow Jones·6d ago

  Annexon Initiated at Market Underperform by Citizens

• Dow Jones·6d ago

  Annexon Price Target Announced at $3.00/Share by Citizens

• Benzinga·6d ago

  Citizens Initiates Coverage On Annexon with Market Underperform Rating, Announces Price Target of $3

• TipRanks·6d ago

  Annexon initiated with an Underperform at Citizens

• TipRanks·07/20 10:20

  Analysts Offer Insights on Healthcare Companies: Sol-Gel Technologies (SLGL), Annexon Biosciences (ANNX) and MindWalk Holdings (HYFT)

• Seeking Alpha·07/20 02:51

  Stay Bullish Despite The Rough Week: Aerospace, Finance, Biotech, And AI

• Simply Wall St·07/18 19:21

  Annexon (ANNX) Could Be 95% Below Fair Value As Phase 3 Progress Reshapes Views

• PUBT·07/16 20:06

  Annexon grants new hires options for 335,000 shares at USD 6.5 each

• Reuters·07/16 20:05

  ANNEXON REPORTS INDUCEMENT GRANTS TO NEW EMPLOYEES UNDER NASDAQ LISTING RULE 5635(C)(4)

• NASDAQ·07/16 03:41

  Top Biotech Gainers: APLM Climbs 22%; IOVA, RCEL On Watch; MANE Gains On Hair Loss Data

• Dow Jones·07/15 11:46

  Annexon Price Target Raised to $25.00/Share From $11.00 by Needham

• Dow Jones·07/15 11:46

  Annexon Is Maintained at Buy by Needham

• Benzinga·07/15 11:35

  Needham Maintains Buy on Annexon, Raises Price Target to $25

• Seeking Alpha·07/15 11:34

  At a glance: stocks gapping up premarket

• TipRanks·07/15 10:50

  Analysts Are Bullish on Top Healthcare Stocks: Incyte (INCY), Annexon Biosciences (ANNX)